Listen up folks and listen WELL: As disclosed by the CEO ofLABS we now have 3 MAJOR announcments pending, not including the name of their global traditional partner.
1) The approval of 2 drugs for the South American market, one already approved
2) The approval by the FDA of a new generic form of Epidiolex
3) DEA rescheduling of cannabis from 1 to 3 for pharmaceutical applications
Anybody whining now about LABS has a hidden motive behind it and the ignore button is a wonderful feature which I recommend all longs to use as well. Let them talk to themselves.